Advances in Pancreatic Cancer Research: Q&A With Christine Iacobuzio-Donahue, MD, PhD
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
This week, scientists from around the world will convene in Orlando, Florida, as the AACR hosts a conference titled...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Eric R. Lutz, PhD, a recipient of the Pancreatic Cancer Action Network-AACR Career Development Award, studies the development of...
Costas Lyssiotis, PhD, a 2013 Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant recipient, is conducting research to understand...
The public craves solid health information, and knowledge about cancer research and treatment is vital to their well-being. The...
Philadelphia Inquirer senior health reporter Marie McCullough describes the challenge of pancreatic cancer and the efforts underway by the...